Mehmet Akcin

Appearances

TRENDS IN NEOADJUVANT CHEMOTHERAPY UTILIZATION AND TREATMENT SEQUENCING FOR GASTRIC CANCER: ARE WE MAKING PROGRESS?
Date
May 20, 2024
Over the past two decades, guidelines for gastric cancer (GC) have shifted. NCCN guidelines recommend chemotherapy for patients with stage IB and beyond…
Presenter
Alexandra Hernandez
Speakers
Yujie Wang
Alan Livingstone
Mehmet Akcin
Cheng-Bang Chen
Jodie Barkin
Laurence Sands
Jose Martinez
Danny Sleeman
Onur Kutlu
MINIMALLY INVASIVE SURGERY FOR GASTRIC ADENOCARCINOMA IS ASSOCIATED WITH BETTER SHORT-TERM OUTCOMES WITHOUT COMPROMISE IN LONG TERM AND ONCOLOGICAL OUTCOMES
Date
May 20, 2024
INTRODUCTION: Utilization of minimally invasive surgery (MIS) for gastric adenocarcinoma has increased consistently. This study investigates the impact of perioperative outcomes on receiving adjuvant chemotherapy and MIS versus open gastrectomy in gastric adenocarcinoma…
Presenter
Alexandra Hernandez
Speakers
Yujie Wang
Alan Livingstone
Mehmet Akcin
Cheng-Bang Chen
Jodie Barkin
Laurence Sands
Jose Martinez
Danny Sleeman
Onur Kutlu